RE:RE:RE:RE:Price
Funny thing is I think Valens is will positioned on the research side and the extract side. The under supply thing is odd. I truly believe the demand for the "flower" product is not going to be crazy. Most people who are interested in marijuana don't want to smoke a big fat blunt and stink like a skunk. Now if ya pass them a little pen full of oil or shatter or whatever extracts are ok(oils medicinally right now) that doesn't smell has a cherry flavor or something people will be all over that. Hence why I think Valens is going to be a company to hold for a long time as they will be at max capacity for processing extracts almost right away is my speculation. That and their research department. All you need is one researcher that finds that one strain with the right CBD that cures Parkinson tremors or counter acts chemo. I mean its a shot in the dark but that is going to be the company that wins. The growers of the world Aurora and Canopy are focused solely on retail sales and medical sales. Research will be the one next big win in this sector.